Neil V. Klinger

Structures of the Class D Carbapenemases OXA-23 and OXA-146: Mechanistic Basis of Activity against Carbapenems, Extended-Spectrum Cephalosporins, and Aztreonam

Kip-Chumba J. Kaitany, Neil V. Klinger, Cynthia M. June et al. · Antimicrobial Agents and Chemotherapy · 2013 · 90 citations · Full text

Bioorganic Chemistry, Mechanistic Basis, Antimicrobial Chemotherapy +16

Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival

Flóra John, Edit Bosnyák, Natasha Robinette et al. · Neuro-Oncology · 2018 · 54 citations · Full text

GNAQ Mutation in the Venous Vascular Malformation and Underlying Brain Tissue in Sturge–Weber Syndrome

Senthil K. Sundaram, Sharon K. Michelhaugh, Neil V. Klinger et al. · Neuropediatrics · 2017 · 49 citations · Full text

Venous Vascular Malformation, Neurological Disorder, Genetics +22

Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors

Anthony R. Guastella, Sharon K. Michelhaugh, Neil V. Klinger et al. · Journal of Neuro-Oncology · 2018 · 49 citations

Tryptophan Metabolism, Neuro-oncology, Tumor Innervation +9

Structural Basis of Activity against Aztreonam and Extended Spectrum Cephalosporins for Two Carbapenem-Hydrolyzing Class D β-Lactamases from <i>Acinetobacter baumannii</i>

Joshua M. Mitchell, Jozlyn R. Clasman, Cynthia M. June et al. · Biochemistry · 2015 · 38 citations · Full text

Antimicrobial Chemotherapy, Antibiotic Resistance, Drug Resistance +20